Cytovance Biologics, a full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, has promoted Matt Hamilton to vice president, finance. Mr. Hamilton will be leading the finance and accounting function. He has been acting vice president of finance for the past ten months and was director of FP&A prior to being promoted.    “With over 18 years’ experience in finance, Matt brings great depth of experience in finance,” said Joyce Johnson, vice president, human re...